Skip to main content

Market Overview

27 Healthcare Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

  • ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD) stock surged 68.5% to $40.09 during Monday's pre-market session. The most recent rating by Stifel Nicolaus, on September 03, is at Hold, with a price target of $28.00.
  • SINTX Technologies, Inc. (NASDAQ: SINT) stock surged 36.2% to $1.88. The market value of their outstanding shares is at $6.5 million.
  • Kitov Pharma, Inc. (NASDAQ: KTOV) shares rose 22.1% to $1.05.
  • Cesca Therapeutics, Inc. (NASDAQ: KOOL) stock surged 15.7% to $4.06.
  • Tyme Technologies, Inc. (NASDAQ: TYME) stock increased by 9.6% to $1.37. The market value of their outstanding shares is at $123.1 million.
  • Phio Pharmaceuticals, Inc. (NASDAQ: PHIO) shares increased by 9.0% to $0.36. The market value of their outstanding shares is at $9.0 million.
  • Outlook Therapeutics, Inc. (NASDAQ: OTLK) shares moved upwards by 7.4% to $1.60. The market cap seems to be at $30.3 million.
  • Mallinckrodt, Inc. (NYSE: MNK) shares moved upwards by 6.7% to $2.00. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.
  • DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) stock increased by 6.3% to $0.67. The most recent rating by Maxim Group, on September 06, is at Buy, with a price target of $2.00.
  • Zosano Pharma, Inc. (NASDAQ: ZSAN) stock increased by 5.6% to $2.25. The market cap stands at $52.1 million.
  • Biohaven Pharmaceutical, Inc. (NYSE: BHVN) stock increased by 5.2% to $43.65. The market cap stands at $1.0 billion. The most recent rating by Morgan Stanley, on July 22, is at Equal-Weight, with a price target of $51.00.
  • Ardelyx, Inc. (NASDAQ: ARDX) stock rose 4.7% to $5.10. The market cap stands at $255.5 million.
  • InMode, Inc. (NASDAQ: INMD) stock increased by 4.0% to $25.10.
  • Advaxis, Inc. (NASDAQ: ADXS) shares surged 3.3% to $0.35. The market cap stands at $8.6 million.
  • OrganiGram Holdings, Inc. (NASDAQ: OGI) stock increased by 3.2% to $5.10. The market cap seems to be at $901.2 million.
  • Aurora Cannabis, Inc. (NYSE: ACB) shares rose 2.6% to $6.24. The market value of their outstanding shares is at $6.3 billion.
  • Microbot Medical, Inc. (NASDAQ: MBOT) shares increased by 2.5% to $7.24. The market value of their outstanding shares is at $64.5 million. The most recent rating by H.C. Wainwright, on July 22, is at Buy, with a price target of $10.00.
  • Cronos Group, Inc. (NASDAQ: CRON) shares moved upwards by 2.5% to $12.23. The most recent rating by Piper Jaffray, on August 13, is at Overweight, with a price target of $18.00.
  • Acasti Pharma, Inc. (NASDAQ: ACST) stock surged 2.3% to $2.20. The market cap stands at $25.6 million. The most recent rating by B. Riley FBR, on August 29, is at Buy, with a price target of $7.75.
  • Tilray, Inc. (NASDAQ: TLRY) shares increased by 2.2% to $32.76. According to the most recent rating by Ladenburg Thalmann, on July 17, the current rating is at Neutral.

 

Losers

  • Cassava Sciences, Inc. (NASDAQ: SAVA) shares plummeted 10.1% to $1.24 during Monday's pre-market session. The market cap stands at $14.6 million.
  • Zafgen, Inc. (NASDAQ: ZFGN) stock fell 4.8% to $0.66. The market cap seems to be at $96.7 million. The most recent rating by Wedbush, on September 06, is at Neutral, with a price target of $0.78.
  • Blueprint Medicines, Inc. (NASDAQ: BPMC) shares plummeted 4.3% to $74.60. The market cap seems to be at $487.4 million. The most recent rating by Piper Jaffray, on August 29, is at Neutral, with a price target of $85.00.
  • Amgen, Inc. (NASDAQ: AMGN) stock decreased by 3.7% to $200.00. The market cap stands at $108.8 billion. The most recent rating by Cantor Fitzgerald, on September 05, is at Neutral, with a price target of $230.00.
  • Mirati Therapeutics, Inc. (NASDAQ: MRTX) shares fell 2.6% to $85.00. The most recent rating by Jefferies, on September 09, is at Buy, with a price target of $105.00.
  • Neon Therapeutics, Inc. (NASDAQ: NTGN) shares decreased by 2.4% to $3.25. The market cap seems to be at $134.2 million. The most recent rating by Baird, on July 26, is at Outperform, with a price target of $15.00.
  • SELLAS Life Sciences, Inc. (NASDAQ: SLS) shares plummeted 2.3% to $0.13. The market value of their outstanding shares is at $27.0 million.
 

Related Articles (ACAD + ACB)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com